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Abstract
Background: Macrophages, osteoclasts, dendritic cells, and microglia are highly specialized cells
that belong to the mononuclear phagocyte system. Functional and phenotypic heterogeneity within
the mononuclear phagocyte system may reveal differentiation plasticity of a common progenitor,
but developmental pathways leading to such diversity are still unclear.
Results: Mouse bone marrow cells were expanded in vitro in the presence of Flt3-ligand (FL),
yielding high numbers of non-adherent cells exhibiting immature monocyte characteristics. Cells
expanded for 6 days, 8 days, or 11 days (day 6-FL, day 8-FL, and day 11-FL cells, respectively)
exhibited constitutive potential towards macrophage differentiation. In contrast, they showed time-
dependent potential towards osteoclast, dendritic, and microglia differentiation that was detected
in day 6-, day 8-, and day 11-FL cells, in response to M-CSF and receptor activator of NFκB ligand
(RANKL), granulocyte-macrophage colony stimulating-factor (GM-CSF) and tumor necrosis
factor-α (TNFα), and glial cell-conditioned medium (GCCM), respectively. Analysis of cell
proliferation using the vital dye CFSE revealed homogenous growth in FL-stimulated cultures of
bone marrow cells, demonstrating that changes in differential potential did not result from
sequential outgrowth of specific precursors.
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Conclusions: We propose that macrophages, osteoclasts, dendritic cells, and microglia may arise
from expansion of common progenitors undergoing sequential differentiation commitment. This
study also emphasizes differentiation plasticity within the mononuclear phagocyte system.
Furthermore, selective massive cell production, as shown here, would greatly facilitate investigation
of the clinical potential of dendritic cells and microglia.
Background
The mononuclear phagocyte system encompasses a wide-
ly distributed family of related cells exhibiting highly spe-
cialized functions such as macrophages, osteoclasts,
dendritic cells, and microglia. Resident macrophages,
found in most organs and connective tissues, serve as pro-
fessional phagocytes, removing pathogens or apoptotic
cells [1]. Microglia represents a unique category of mono-
nuclear phagocytes distributed throughout the central
nervous system (CNS) parenchyma in both white and
grey matter [2]. Microglial cells share a number of immu-
nological markers with other mononuclear phagocytes,
yet they present a unique ramified morphology, which is
best characterized by electron microscopy [3]. Besides
their role as immune effectors of the CNS, microglial cells
exert non-immunological functions, including produc-
tion of neurotrophic factors and glutamate uptake [4,5].
Dendritic cells (DCs) are specialized in capturing antigens
and initiating immune response through naive T-cell acti-
vation [6], and are also implicated in maintaining toler-
ance to self-antigen [7]. The diverse functions of DCs in
immune regulation are dictated by the instructions they
received during innate immune responses to different
pathogens, but DC response may be also lineage-depend-
ent as distinct myeloid and lymphoid DC lineages have
been recently identified [8]. Osteoclasts are multinucleat-
ed, adherent, bone-resorbing cells found in the bone vi-
cinity. They play an essential role in bone remodelling, as
well as in regulating calcium homeostasis [9].
Functional and phenotypic heterogeneity within the
mononuclear phagocyte system may reveal differentiation
plasticity of a common progenitor, but the developmental
pathways leading to macrophages, osteoclasts, DCs, or
microglia are still unclear. Cell transfer experiments have
established that alveolar macrophages in the lung, and
Kupfer cells in the liver, derive from mature monocytes
[10]. Late monocyte precursors have been shown to differ-
entiate into osteoclasts in response to macrophage colo-
ny-stimulating factor (M-CSF) and receptor activator of
NFκB ligand (RANKL) [9,11]. Similarly, DCs could be de-
rived from circulating human monocytes following stim-
ulation with GM-CSF and interleukin-4 [12], or from
human CD34+ myeloid progenitors using GM-CSF and
tumor necrosis factor-α (TNFα) [13]. Furthermore, bone
marrow progenitors were recently identified through their
ability to differentiate into DCs or osteoclasts, depending
on whether RANKL was combined to granulocyte-macro-
phage colony stimulating-factor (GM-CSF) or M-CSF, re-
spectively [14]. Whereas microglia has been well
characterized in vivo and in vitro, little is known about mi-
croglial precursors, and attempts to induce in vitro micro-
glial differentiation of mature or immature monocytes
have been unsuccessful [3,15]. However, recent in vivo
studies have shown that microglia and other CNS resident
cells (macroglia and neurons) are continuously renewed
from as yet uncharacterized progenitors originating from
the adult bone marrow which are, themselves or their
progeny, able to cross the blood-brain barrier and give rise
to mature microglia [16,17]. Altogether, data from the lit-
erature plead for the myeloid origin of macrophages, os-
teoclasts, DCs, and microglia. However, a global approach
proved necessary for delineating lineage relationships
within the mononuclear phagocyte system. In particular,
learning how cellular diversity is generated in this cellular
system is of great importance regarding cellular or gene
therapy protocols.
Here we describe ex vivo expansion of murine myeloid
cells in response to Flt3 ligand (FL) and investigate their
response to cytokines inducing differentiation towards
macrophages (M-CSF), osteoclasts (M-CSF plus RANKL),
dendritic cells (GM-CSF plus TNFα), or microglia (glial-
cell conditioned medium: GCCM). Results support a
model based on the sequential commitment of Flt3+
bone-marrow progenitors.
Results
FL expands a continuum of macrophage precursors from 
mouse bone marrow cells
FL exerts potent stimulatory effects on precursors of the
monocyte/macrophage lineage, alone or in combination
with M-CSF [10,18]. Furthermore, it was recently shown
that FL stimulates generation of DC precursors [19,20] or
macrophages [18] when used alone, and that of osteo-
clasts in combination with RANKL [21]. In our condi-
tions, bone marrow cell proliferation was observed for at
least 11 days in the presence of FL (Figure. 1A). FL was
used at 5 ng/ml FL throughout the present study, as this
dose was sufficient to initiate bone-marrow cell prolifera-
tion (Figure. 1B). More than 90% of non-adherent day 6
cells (day 6-FL cells) and day 8 cells (day 8-FL cells) were
viable cells, but FL-stimulated cultures showed decreasing
cell viability from day 8 of culture (not shown). Re-feed-BMC Immunology 2002, 3 http://www.biomedcentral.com/1471-2172/3/15
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ing day-8 cultures with 5 ng/ml FL resulted in only slightly
increased viability of day-11 FL cells while it strongly stim-
ulated cell proliferation (data not shown).
Next, we asked whether FL-stimulated growth between
day 6 and day 11 could be accounted for by continuous
expansion of a common progenitor cell population. Us-
ing CFSE labelling, we show that day 6-FL cells as well as
day 8-FL cells actively and synchronously divided, consist-
ent with rapid and homogeneous outgrowth of FL-cells
(Fig. 1C). We conclude that the whole day 6-FL cell popu-
lation generates day 8-FL cells that are precursors of day
11-FL cells.
Day 6-FL cells express a homogeneous immunopheno-
type suggestive of maturing monocytic cells: CD11b+,
CD115+ (M-CSF receptor) and F4/80-, a macrophage
marker (Fig. 2A). Consistently, cells showed high nucleus/
cytoplasm ratio, basophilic cytoplasm and bean- or ring-
shaped nuclei (Fig. 2B). At later culture times, FL-stimulat-
ed cells maintained CD11b expression, but acquired ex-
pression of markers expressed on DCs, such as DEC 205
and CD11c, at day 8, and F4/80, at day 11 (Fig. 2A). Mod-
ulation of cell-surface marker expression suggested that
FL-cells might develop various differentiation potentials
along with culture duration.
Macrophage potential of day 6-FL cells can be directed to-
wards osteoclast differentiation
Stimulation of day 6-FL cells with M-CSF for 4 days result-
ed in limited proliferation, then differentiation into ad-
herent (Fig. 3A), phagocytic (Fig. 3B) macrophage-like
cells. Accordingly, morphology changes were accompa-
nied by decreased CD34 and CD135 (Flt3) expression,
but increased CD11b levels and induced F4/80 expression
(Fig. 3C). Similarly, day 8-FL cells and day 11-FL cells dif-
ferentiated to macrophages in response to M-CSF, as
shown by expression of F4/80 and CD11b antigens (Fig.
3D), correlating with level of CD115 expression (Fig. 2A).
To determine whether FL-expanded precursors could be
committed towards osteoclasts, a combination of M-CSF
and RANKL was applied to day 6-FL cells, in the absence
of FL. After 6 days of this treatment, large multinucleated
cells were formed and all cells in the cultures were express-
ing tartrate-resistant acidic phosphatase (TRAP) activity, a
classical osteoclast marker (Fig. 4A). Overall, when grown
on dentin slices, cells formed typical resorption pits indi-
cating that they were functional osteoclasts (Fig. 4B).
Figure 1
FL promotes outgrowth of immature monocytic
cells from mouse bone marrow in vitro (A) FL expanded
non-adherent cells were counted after different culture dura-
tions. Data are expressed as % of initial cell number and rep-
resent mean ± SEM of five independent experiments (3
experiments for day 11). (B) FL-dose-dependent proliferation
was assessed by using the MTT assay after 6 days of culture
in 96-well plates. Data are mean ± SEM of three independent
experiments. (C) Tracking division of day 6-FL cells (left
panel) and day 8-FL cells (right panel). Cells were stained
with CFSE then used for reseeding original culture flasks.
Division number is indicated based on sequential halving of
CFSE fluorescence. Data are representative of three inde-
pendent experiments.
Figure 2
Characterization of FL cultivated cells. (A) Flow cytom-
etry analyses of day 6-, day 8-, and day 11-FL cells. Filled his-
tograms: expression levels of the markers indicated, dotted
line: background staining with irrelevant antibodies. Results
are representative of 3 to 5 independent experiments. Num-
bers represent the average percentage of positive cells. (B)
May Grünwald Giemsa reagent staining of day 6-FL cells.BMC Immunology 2002, 3 http://www.biomedcentral.com/1471-2172/3/15
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Macrophage potential of day 8-FL cells can be directed to-
wards myeloid-related DC differentiation
Flt3+ myeloid progenitors purified from mouse bone mar-
row have been shown to generate both CD8α- and CD8α+
DCs in FL-supplemented cultures [19]. In preliminary ex-
periments, we sought for culture conditions that could
specifically generate myeloid-related DCs and found that
a combination of GM-CSF and TNFα triggered a pure my-
eloid-related DC differentiation of day 8-FL cells. Differ-
entiation occurred in the absence of [3H]-thymidine
incorporation, but cell viability was greater than 90% (not
shown), indicating massive differentiation of day 8-FL
cells. Mature DC differentiation was assessed by pheno-
typic, morphological and functional analysis. CD11b ex-
pression was maintained, but cells acquired CD11c+,
CD86high, MHCIIhigh, CD80high, CD40+, and CD25high
expression (Fig. 5A), and were negative for CD8α, B220,
IgM, CD3 and CD71 antigens (not shown). Consistent
with mature DC immunophenotype, cells displayed a typ-
ical dendritic morphology (Fig. 5B) and elicited greatly
enhanced allogeneic T-cell response compared to syn-
geneic stimulation (Fig. 5C), whereas they were unable to
effectively phagocyte latex beads (data not shown).
Interestingly, addition of TGFβ directed DC differentia-
tion towards immature immunophenotype (CD80low,
CD86low, MHCIIlow; see Fig. 5A), morphology (shorter
dendrites; see Fig. 5D), and function, as they could phago-
cyte latex beads (Fig. 5E). They were also potent allostim-
ulatory cells (data not shown). These cells represent a
double-negative CD4-/CD8- immature DC population
but not typical Langerhans cells, as they do not contain
any Birbeck granules (not shown).
Figure 3
Macrophage differentiation in response to M-CSF (A)
Day 6-FL cells were stained with May Grünwald Giemsa rea-
gent after 4 days of culture in M-CSF (500 U/ml). (B) Phago-
cytic activity of M-CSF-differentiated day-6 FL cells is shown
by ingestion of brown latex beads. (C) Flow cytometry analy-
sis of CD11b, F4/80, CD34 and CD135 expression on M-
CSF-differentiated day 6-FL cells. (D) Flow cytometry analysis
of CD11b and F4/80 expression on M-CSF-differentiated day
6-, day 8-, and day 11-FL cells.
Figure 4
Osteoclast differentiation of day 6-FL cells (A) Day 6-
FL cells cultivated for 6 days in the presence of M-CSF and
RANKL formed mixed population of large multinucleated
cells together with mononucleated cells. Note that 100% of
the cells are TRAP-positive, as indicated by their blue stain-
ing. (B) When grown on top of dentin slices, cells actively
resorbed dentin as shown by arrows pointing to the toluidin
blue stained resorption pits.
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Late commitment of macrophage precursors towards mi-
croglia differentiation
In order to evaluate microglia differentiation potential,
day 11-FL cells were cultured for 3 or 6 days with or with-
out 50% GCCM. Microglia cells share a number of immu-
nological markers with other classes of mononuclear
phagocytes but present a unique morphology character-
ized by the presence of multiple cellular processes and mi-
cro-spikes or spines [3]. GCCM-treated day 11-FL cells
adhered to plastic, maintained CD11b expression (Fig.
6A, 6B) and 20% of cells developed a ramified morphol-
ogy and bore actin-filled micro-spikes and pseudopodia
(Fig. 6C). By performing electron microscopy on differen-
tiated day 11-FL cells, we were able to ascertain the typical
morphological features which characterize microglia in
vitro[3]: thread-like structures of 0.05 nm diameter and
cellular processes bearing numerous cell-surface spines of
0.1 nm diameter (Fig. 6D). After 6 days of GCCM treat-
ment, process length reached more than 3 times the cell
body diameter in 20% of cells (Fig. 6E), and more numer-
ous thread-like structures were observed by electron mi-
croscopy (Fig. 6E, insert). As reported for cultured
microglia [2,22], differentiated day 11-FL cells exhibited
high cell surface expression of the macrophage markers
CD115, CD11b and F4/80, and low or undetectable ex-
pression of CD80, CD86 (Fig. 6F) and MHC class II anti-
gen (data not shown).
Differentiation plasticity of FL-expanded macrophage 
precursors is time-dependent
In experiments reported above, FL cells reproducibly dif-
ferentiated into macrophages in response to M-CSF, what-
ever duration of the primary culture. Differentiation to
osteoclasts, DCs, and microglia was obtained by cultivat-
ing day 6-, day 8- and day-11 FL cells in the presence of M-
CSF and RANKL, GM-CSF and TNFα, or GCCM, respec-
tively. Time-course studies showed that these conditions
were optimal (Fig. 7). Indeed, osteoclast differentiation
sharply decreased between day 6 and day 11 of primary
cultures (Fig. 7A). Differentiation to mature DCs in re-
sponse to GM-CSF and TNFα combination was maximal
with day 8-FL cells, as shown by CD11c expression (Fig.
7B). Finally, percentage of typical microglial cells ob-
tained in response to GCCM reached a peak using day 11-
FL cells (Fig. 7C). These data clearly confirmed that differ-
entiation ability of macrophage precursors was dependent
on the duration of the primary cultures.
Discussion
The culture system described here is to our knowledge the
first to enable mass selective production of pure osteo-
clasts, pure CD8α- DCs, and pure macrophages, thus pro-
viding a unique tool to study primary cells from the
mononuclear phagocyte system. Indeed, bone marrow
from a single mouse (7–10 × 107 cells) currently yields 1–
Figure 5
Day 8-FL cells can differentiate into immature or
mature DCs depending on the presence of TGFβ (A)
Flow cytometry analyses were performed on day 8-FL cells
at day 0 and 5 after culture in the presence of 5 ng/ml GM-
CSF plus 10 ng/ml TNF-α without or with 10 ng/ml TGF-β.
Numbers are the percentages of total viable cells. Controls
are positioned by quad limits and dotted histograms. Data
are representative of 5 experiments. (B) Day 8-FL cells cul-
tured for 5 days in the presence of GM-CSF+TNF-α showed
mature DC morphology in culture. (C) Comparison of allo-
and syngeneic stimulatory activities of day 8-FL-derived
mature DCs generated from C57BL/6 mice after 5 days of
culture in GM-CSF+TNF-α. Results are expressed as mean
cpm ± SD from triplicate cultures and shown for one tripli-
cate experiment representative of three. (D) GM-CSF+TNF-
α+TGFβ- derived DCs showed immature morphology after
May Grünwald Giemsa staining and (E) phagocytic activity.
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2 × 107 osteoclasts, 2–3 × 108 DCs, or 1–2 × 108 macro-
phages. In particular, this protocol will facilitate investiga-
tions on genetically modified cells obtained from
transgenic or knockout mice, or following retrovirus-me-
diated cell transfer.
CFSE monitoring of cell division demonstrated that most
day 6-FL cells are precursors of day 8-FL cells. Both cell
types were shown to be macrophage precursors endowed
with osteoclast or prominent DC differentiation poten-
tial, respectively. As both proliferation and cell mortality
were limited or absent during the differentiation process
(not shown), we conclude that osteoclast or DC differen-
tiation of FL cells was not preceded by preferential expan-
sion of distinct precursor sub-populations. Thus we
propose that Flt3+ macrophage precursors commit se-
quentially to osteoclast and DC differentiation, possibly
through time-dependent expression of intracellular fac-
tors. Consistent with this model, Miyamoto et al. have re-
cently demonstrated that M-CSF and GM-CSF regulate
differentiation of osteoclasts and DC from a common pre-
cursor whether they express c-Fos or not, respectively [14].
It remains to be shown whether FL-expanded osteoclast
precursors are identical or not to those previously de-
scribed by Arai et al. [11].
The protocol described in the present paper also repre-
sents a powerful tool for studying microglia differentia-
tion control mechanisms. It now becomes possible to
determine which soluble factors in GCCM induce micro-
glia differentiation. In addition to macrophages and mi-
croglia, day 11-FL cells could also differentiate to DCs (30
to 40%), though less efficiently than day 8-FL cells (>
90%). It was recently suggested that native microglia are
uncommitted precursors of DC and macrophages [23].
However, it is not clear whether this results from micro-
glia plasticity or de-differentiation to an uncommitted
precursor. In that respect, day 11-FL cells, that have no mi-
croglia characteristics, may represent a valuable model to
delineate the relationship between DC and microglia
pathways.
Facilitating  in vitro studies on microglia differentiation
may help to shed some light on several physiopathologi-
cal processes. Indeed, microglia is the principal immuno-
effector cell located in the CNS parenchyma, and its
involvement in pathogenesis has been established for nu-
merous neurological conditions including stroke, trauma
and Alzheimer's disease [24]. Furthermore, bone marrow-
derived progenitors committed to microglial differentia-
tion should be ideally suited for CNS-targeted gene thera-
py since they may be able to migrate from blood to brain
through an intact blood-brain barrier [16,17,25].
The unique DC properties of either eliciting immunity or
ensuring self-tolerance [7], make them candidates for en-
hancing responses against foreign antigens in vaccination
protocols [26] and against tumor antigens in cell immu-
notherapy [27], as well as making them targets for the
treatment of autoimmunity and allograft rejection [6].
Whether mature or immature DCs should be targeted in
Figure 6
Characterization of day 11-FL cells differentiated
into microglial cells (A) CD11b staining of day 11-FL cells
cultured for 3 days in presence of fresh media alone. (B)
CD11b staining of day 11-FL cells cultured for 3 days in pres-
ence of 50% GCCM. (C) Actin-phalloidin staining of day-11
FL cells cultured for 3 days in presence of 50% GCCM. Note
the presence of actin-filled spines and pseupodia (white
arrow). (D) Electron microscopy photomicrograph of day
11-FL cells cultured for 3 days in presence of 50% GCCM.
Differentiated cells exhibited cell processes bearing spines of
0.1 µm diameter (black arrows). (E) After 6 days in the pres-
ence of GCCM, cells exhibited longer processes expanding
from the cell bodies as shown by phase-contrast microscopy.
Insert shows typical thread-like structures of 0.05 µm diame-
ter (dashed arrow). (F) FACS profiles compare immunophe-
notype of day 11-FL cells and adherent cells obtained after
cultivating day 11-FL cells for 3 days in the presence of 50%
GCCM.
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these various fields is a matter of debate that could be
solved with the two culture conditions described, with
and without the use of TGFβ. These last years, substantial
progress were made to characterize distinct subsets of
DCs, based on differential phenotype and function, both
in humans and mice. In mice, all DC subsets described so
far express CD11c [28]. CD8α homodimer expression
now appears to be more related to maturation state than
lineage origin [8]. Flow cytometry analysis of spleen cells
from mice treated with FL for 9 days reveals five pre-DC or
DC subpopulations that occur in distinct microenviron-
ments of the spleen [29]: two putative immature popula-
tions, CD11b+ Ly6C+ Gr-1+ (named A, B), and three
CD11c+ DC populations distinguished by CD8α and
CD11b expressions (named C, D, E). Although phenotyp-
ic characterization of these DCs does not exactly fit to the
in vitro FL-derived DCs presented in this work, latter cells
are closely related to spleen DCs of myeloid origin, re-
ferred to as population C by Pulendran et al.[29].
Plasmacytoid DCs, also called interferon producing cells
(IPC) were recently characterized in humans and mice
[30–33]. Both myeloid and plasmacytoid DCs were clear-
ly expanded by FL in vivo, with or without GM-CSF mobi-
lization [33]. Recently, Gilliet et al. demonstrated that
plasmacytoid DC precursors are differentially regulated by
FL and GM-CSF [20]. Though cellular phylogeny between
Flt3+ progenitors and DCs become more and more clear,
the relationships between Flt3+ bone-marrow progenitors
(0.3% of total bone marrow cells), lymphoid progenitors
and myeloid progenitors remains to be clarified. Concern-
ing functional aspects, DC-dependent T-cell polarizing ac-
tivity (Th1-, Th2-, Th3- or Tr-type) is not related to lineage
origin, but rather depends on the stimuli used to activate
these cells, probably due to their equipment and subse-
quent transduction of pathogen associated molecular pat-
tern receptors, such as Toll receptor family [34].
Conclusions
Based on the present study and data from the literature,
we propose a model where early Flt3+ progenitors commit
themselves to a sequential differentiation program pro-
ceeding through narrow windows; each time window cor-
responds to expression of a specific differentiation
potential (Fig. 8). A first phase of selection (hatched line),
likely through apoptotic death of Flt3- cells, would lead to
Flt3+ cell expansion (plain line). Each time window may
permit generation of different types of precursors able to
differentiate into osteoclasts, then into DCs, and finally,
for 25% of day 11-FL cells, into microglia cells. Moreover,
FL cells can differentiate to macrophages in response to M-
CSF whatever the duration of primary culture in FL.
Data obtained with transgenic FL-mice and FL deficient
mice support a major role of FL in DC development [35].
Figure 7
Differentiation potential of FL cells is time depend-
ent Day 6-, day 8-, and day 11-FL cells were differentiated to
osteoclasts, DCs, and microglia using specific cytokine com-
binations. Percentage of differentiated cells was measured as
specified below. (A) Cells were grown in presence of M-CSF
and RANKL and the number of osteoclasts was counted 6
days later. Similar results have been consistently obtained in
several experiments. (B) Cells were treated by GM-CSF and
mature DC percentage was determined by flow cytometry
determination of CD11c+ cells. Results are representative of
3 independent experiments. (C) Microglia differentiation was
assessed by detection of ramified cells after cultivating the
cells for 6 days in the presence of GCCM. This experiment is
representative of 4 independent experiments.
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In contrast, development of DC lineages is almost normal
in lymphoid organs of mice deficient for GM-CSF or GM-
CSF receptor [36]. It would be interesting to test whether
DC differentiation from FL cultivated cells is dependent
on the presence of GM-CSF, or whether it could be ob-
tained in the presence of proinflammatory cytokines or
bacteria-derived products, as recently shown [19]. Indeed,
an attractive hypothesis would be that DCs represent the
default cell type in the progeny of Flt3+ progenitors, un-
less appropriate microenvironment stimulation is added
to differentiate progenitors to osteoclasts (M-CSF and
RANKL), macrophages (M-CSF) or microglia (GCCM).
Nevertheless, the picture emerging from our study is that
diversity within the mononuclear phagocyte system is
generated from a continuum of macrophage precursors
whose differentiation potential might change as a func-
tion of relative ageing and cytokine environment. Wheth-
er this sequential commitment process is cell-
autonomous or depends on paracrine/autocrine loops re-
mains to be determined. However, in vivo experiments
have clearly shown that tissue macrophages may differen-
tiate into lymph-node DCs when exposed to a phagocytic
stimuli [37]. Moreover, microglia could be induced to ac-
quire specific DC or macrophage markers when exposed
to GM-CSF or M-CSF, respectively [23]. Thus, mature
macrophages, DCs, or microglia, may activate latent dif-
ferentiation programs under appropriate stimuli. We have
shown here that macrophage precursors show more limit-
ed differentiation potential, raising the attractive possibil-
ity that mature cells cells of the mononuclear phagocyte
system are more capable of differentiation plasticity than
their precursors.
Methods
FL-cell production and proliferation
Total bone marrow cells from C57BL/6 mice (IFFA-CRE-
DO, France) were seeded at 5 × 105 cells/mL in Iscove's
Modified Dulbecco's Medium (IMDM; Life Technologies)
Figure 8
Model showing the sequential commitment of FL-expanded precursors to macrophages, osteoclasts, dendritic
cells, and microglia GCCM: glial cell-conditioned medium; IPC: interferon producing cells.
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supplemented with 15% fetal calf serum (FCS; Dutscher)
and 5 ng/mL human FL (R&D Systems). Indeed, prelimi-
nary experiments indicated that human FL was as efficient
as murine FL in stimulating bone marrow cell prolifera-
tion (data not shown). Cultures were performed at 37°C,
5% CO2. After different durations of culture, as specified
in the text, non-adherent cells were recovered following
gentle flushing of the culture flasks, and therefore desig-
nated as FL-cells. For FL-dose response studies, cells were
cultivated under the same conditions in 0.1 mL of culture
medium per each culture well in 96-well plates. Prolifera-
tion was assessed after 6 days of culture using the MTT as-
say, which was performed as previously described [38].
For cell division studies, non-adherent cells were harvest-
ed from FL-stimulated cultures at day 6 or day 8, stained
with carboxyfluorescein diacetate, succinimidyl ester
(CFSE) as previously described [39], and cultured for du-
rations as indicated. In order to ensure optimal growth,
culture medium and flask were re-used for culturing CFSE
labelled cells.
Macrophage differentiation in vitro
FL-cells were cultured for 4 days in the presence of 500 U/
ml M-CSF. The source of M-CSF was supernatant from Sf9
insect cells expressing murine M-CSF from a baculovirus
vector. One unit was defined as being able to stimulate
one colony from 50,000 mouse bone marrow cells in
standard agar cultures [40].
Osteoclast differentiation and characterization
Cells were seeded at 1.8 × 105 cells/well of 24-well plates
in  α-MEM medium (Life technologies) supplemented
with 10% FCS (Hyclone), 1% glutamine, in the presence
of M-CSF (500 U/mL) and human RANKL (3% of super-
natant from RANKL cDNA-expressing yeast, correspond-
ing to about 30 ng/ml of recombinant RANKL). TRAP
activity in osteoclast cultures was identified by using the
Leukocyte acid phosphatase kit (Sigma). For assessing re-
sorption activity, cells were maintained on dentin slices
for 14 days in a 10% CO2 incubator. Following cell re-
moval, dentin slices were stained with toluidin blue to re-
veal resorption pits under microscope [41].
Dendritic cell differentiation and functional characteriza-
tion
FL cells were seeded at 106/ml in RPMI 1640 supplement-
ed with 10 mM Hepes, 2 mM L-glutamine, 40 µg/ml gen-
tamycine, 10% FCS (Gibco-BRL), 5 × 10-5 M β-mercapto-
ethanol (Sigma) and 5 ng/ml murine GM-CSF, 10 ng/ml
murine TNF-α with or without 10 ng/ml human TGF-β
(Peprotech). Additional 50% Percoll gradient permitted
to enhance DC purity from 60–80% to >90%.
For assessing syngeneic or allogenic stimulation, cells
were cultured in various numbers in presence of a con-
stant number (105/well) of T cells purified from either
C57BL/6 or DBA/2 mice. DNA synthesis was assessed after
an 8-h pulse with 1 µCi [3H]TdR.
Microglia cell differentiation
Cells were washed once in PBS then cultured for 6 days at
5 × 105 cells/ml in 50% GCCM and 50% DMEM contain-
ing 10% FCS. To obtain GCCM, C57BL/6 mice were sacri-
ficed on postnatal day 2, meninges were removed and
mechanically dissociated cortices were cultivated for 10
days on polyornithine-coated dishes in DMEM supple-
mented with FCS 10% (Gibco Life Technologies). Culture
supernatant was referred to as GCCM. Following culture
in the presence of GCCM, adherent cells were either
trypsinized and collected for FACS analysis, acetone-fixed
for fluorescence studies or fixed with glutaraldehyde be-
fore electron microscopy analysis. For electron microsco-
py, cells were fixed directly in the culture flasks for 60 min.
with glutaraldehyde in 0.1 M cacodylate buffer, postfixed
in 0.1% osmium tetroxide, and dehydrated in graded eth-
anol solution. Gelatin capsules filled with araldite solu-
tion were put upside down over selected culture areas and
polymerized at 60°C during 24 h before they were split
from the culture flask. Ultrathin sections were contrasted
with uranyl acetate and lead citrate. To visualize actin fil-
aments, acetone-fixed cells were incubated with phalloi-
din-fluorescein (Sigma) for 50 min. at room temperature
before washing in PBS.
FACS analysis
For immunofluorescence staining, 5 × 105 cells were incu-
bated for 15 min. on ice with anti-CD16/32 monoclonal
antibody (clone 24G2; Fc-Block reagent, Pharmingen),
then FITC or phycoerythrin-conjugated antibodies were
added for 40 min. incubation on ice. Cells were washed
once in PBS before performing fluorescence analysis on a
FACScan (Becton-Dickinson). Signal acquisition and re-
sult analysis were performed using Cell Quest software
(Becton-Dickinson). Monoclonal antibodies used here
were as follows: anti-CD4 (clone RM4-5), CD8α (5H10),
B220 (RA3-6B2), F4/80 (clone CI:A3-1), and CD34
(clone MEC14.7) were from Caltag; anti-CD11b (clone
M1/70), CD11c (clone HL3), CD40 (clone 3/23), CD80
(clone 16-10A1), CD86 (clone GL1), CD135 (clone
A2F10.1), and MHC II (Iab; clone 25-9-17), were from
Pharmingen; anti-CD25 (clone PC615.3) was from Coul-
ter-Beckman. For staining with anti-CD115 (clone 2E-11,
ref. [42]), cells were first incubated with goat IgG (Sigma)
for 15 min. on ice, then 2E-11 antibody was added for a
40-min. incubation on ice. After washing in PBS, cells
were resuspended in fluorescein conjugated F(ab')2 frag-
ments of goat anti-rat immunoglobulins (Caltag) for a 40
min. incubation anice.BMC Immunology 2002, 3 http://www.biomedcentral.com/1471-2172/3/15
Page 10 of 11
(page number not for citation purposes)
Authors' contributions
CSD, SA, PJ, and SN contributed equally to this work.
CSD conducted and performed experiments on DC po-
tential, participated to FL cell immunophenotyping, and
drafted corresponding parts of the manuscript; SA set up
conditions for FL expansion of mouse bone marrow cells;
PJ conducted experiments on osteoclastic potential and
drafted the corresponding part of the manuscript; SN con-
ducted experiments on microglia potential and drafted
the corresponding part of the manuscript; MFG obtained
the various FL cell populations studied here and per-
formed CFSE experiments; CS carried out studies on mac-
rophage differentiation potential; CD and OD carried out
experiments on osteoclast differentiation and characteri-
zation; AR and MP participated in the study of DC differ-
entiation; CD performed electron microscopy analyses;
DH performed studies on Birbeck granules in DC differen-
tiated cells; GRG was instrumental in providing anti-
CD115 monoclonal antibody which greatly help to set up
and standardize FL culture conditions; MFB and CRC are
heads of groups working on microglia and DC, respective-
ly; GM coordinated the study and participated to flow cy-
tometry analyses.
Acknowledgements
Human RANKL cDNA was a generous gift of Osteopro, Denmark. Dentin 
slices were generous gifts from Dr T. Suda (Tokyo, Japan) and DrN. Taka-
hashi (Nagano, Japan). This work was supported by grants from Centre Na-
tional pour la Recherche Scientifique; INSERM; Association pour la 
Recherche sur le Cancer (grants 5753 and 5738); Ligue Nationale contre le 
Cancer (label "La Ligue" for GM's group) and Comité du Rhône de la Ligue; 
Région Rhone-Alpes (Programme Emergence); S.N. and O.D. were sup-
ported by grants from the Fondation pour la Recherche Médicale and the 
Ministère de l'Enseignement et de la Recherche. The authors wish to thank 
Larry R. Rohrschneider for critical review of the manuscript.
References
1. Gordon S: The macrophage. Bioessays 1995, 17:977-986
2. Perry VH: A revised view of the central nervous system mi-
croenvironment and major histocompatibility complex class
II antigen presentation. J Neuroimmunol 1998, 90:113-121
3. Giulian D, Li J, Bartel S, Broker J, Li X, Kirkpatrick JB: Cell surface
morphology identifies microglia as a distinct class of mono-
nuclear phagocyte. J Neurosci 1995, 15:7712-7726
4. Elkabes S, DiCicco-Bloom EM, Black IB: Brain microglia/macro-
phages express neurotrophins that selectively regulate mi-
croglial proliferation and function.  J Neurosci 1996, 16:2508-
2521
5. Noda M, Nakanishi H, Nabekura J, Akaike N: AMPA-kainate sub-
types of glutamate receptor in rat cerebral microglia. J Neu-
rosci 2000, 20:251-258
6. Banchereau J, Steinman RM: Dendritic cells and the control of
immunity. Nature 1998, 392:245-252
7. Steinman RM, Turley S, Mellman I, Inaba K: The induction of toler-
ance by dendritic cells that have captured apoptotic cells. J
Exp Med 2000, 191:411-416
8. Traver D, Akashi K, Manz M, Merad M, Miyamoto T, Engleman EG,
Weissman IL: Development of CD8alpha-positive dendritic
cells from a common myeloid progenitor.  Science 2000,
290:2152-2154
9. Teitelbaum SL: Bone resorption by osteoclasts.  Science 2000,
289:1504-1508
10. Kennedy DW, Abkowitz JL: Mature monocytic cells enter tis-
sues and engraft. Proc Natl Acad Sci U S A 1998, 95:14944-14949
11. Arai F, Miyamoto T, Ohneda O, Inada T, Sudo T, Brasel K, Miyata T,
Anderson TM, Suda T: Commitment and differentiation of os-
teoclast precursor cells by the sequential expression of c-
Fms and receptor activator of nuclear factor kappaB
(RANK) receptors. J Exp Med 1999, 190:1741-1754
12. Sallusto F, Lanzavecchia A: Efficient presentation of soluble anti-
gen by cultured human dendritic cells is maintained by gran-
ulocyte/macrophage colony-stimulating factor plus
interleukin 4 and downregulated by tumor necrosis factor al-
pha. J Exp Med 1994, 179:1109-1118
13. Caux C, Vanbervliet B, Massacrier C, Dezutter-Dambuyant B, de
Saint-Vis B, Jacquet C, Yoneda K, Imamura S, Schmitt D, Banchereau
J: CD34+ hematopoietic progenitors from human cord blood
differentiate along two independent dendritic cell pathways
in response to GM-CSF+TNF alpha. J Exp Med 1996, 184:695-
706
14. Miyamoto T, Ohneda O, Arai F, Iwamoto K, Okada S, Tagaji K, An-
derson D, Suda T: Bifurcation of osteoclasts and dendritic cells
from common progenitors. Blood 2001, 98:2544-2554
15. Wilms H, Wollmer MA, Sievers J: In vitro-staining specificity of
the antibody 5-D-4 for microglia but not for monocytes and
macrophages indicates that microglia are a unique subgroup
of the myelomonocytic lineage. J Neuroimmunol 1999, 98:89-95
16. Brazelton TR, Rossi FM, Keshet GI, Blau HM: From marrow to
brain: expression of neuronal phenotypes in adult mice. Sci-
ence 2000, 290:1775-1779
17. Mezey E, Chandross KJ, Harta G, Maki RA, McKercher SR: Turning
blood into brain: cells bearing neuronal antigens generated
in vivo from bone marrow. Science 2000, 290:1779-1782
18. Nicholls SE, Winter S, Mottram R, Miyan JA, Whetton AD: Flt3 lig-
and can promote survival and macrophage development
without proliferation in myeloid progenitor cells. Exp Hematol
1999, 27:663-672
19. Brasel K, De Smedt T, Smith JL, Maliszewski CR: Generation of
murine dendritic cells from flt3-ligand-supplemented bone
marrow cultures. Blood 2000, 96:3029-3039
20. Gilliet M, Boonstra A, Paturel C, Antonenko A, Xu XL, Trinchieri G,
O'Garra A, Liu YJ: The development of murine plasmacytoid
dendritic cell precursors is differentially regulated by FLT3-
ligand and granulocyte/macrophage colony-stimulating fac-
tor. J Exp Med 2002, 195:953-958
21. Lean JM, Fuller K, Chambers TJ: FLT3 ligand can substitute for
macrophage colony-stimulating factor in support of osteo-
clast differentiation and function. Blood 2001, 98:2707-2013
22. Carson MJ, Reilly CR, Sutcliffe JG, Lo D: Mature microglia resem-
ble immature antigen-presenting cells. Glia 1998, 22:72-85
23. Santambrogio L, Belyanskaya SL, Fischer FR, Cipriani B, Brosnan CF,
Ricciardi-Catagnoli P, Stern LJ, Strominger JL, Riese R, et al: Devel-
opmental plasticity of CNS microglia. Proc Natl Acad Sci U SA
2001, 98:6295-6300
24. Kreutzberg GW: Microglia, a sensor for pathological events in
the CNS. Trends Neurosci 1996, 19:312-318
25. Priller J, Flugel A, Wehner T, Boentert M, Haas CA, Prinz M, Fernan-
dez-Klett F, Prass K, Bechmann I, de Boer AB, et al: Targeting of
gene-modified hematopoietic cells to the central nervous
system: use of green-fluorescent protein uncovers microglial
engrafment. Nat Med 2001, 7:1356-1361
26. Su H, Messer R, Whitmire W, Fischer E, Portis JC, Caldwell HD: Vac-
cination against chlamydial genital tract infection after im-
munization with dendritic cells pulsed ex vivo with nonviable
Chlamydiae. J Exp Med 1998, 188:809-818
27. Fong L, Engleman EG: Dendritic cells in cancer immunotherapy.
Annu Rev Immunol 2000, 18:245-273
28. Maraskovsky E, Brasel K, Teepe M, Roux ER, Lyman SD, Shortman K,
McKenna HJ, et al: Dramatic increase in the numbers of func-
tionally mature dendritic cells in Flt3 ligand-treated mice:
multiple dendritic cell subpopulations identified. J Exp Med
1996, 184:1953-1970
29. Pulendran B, Lingappa J, Kennedy MK, Smith J, Teepe M, Rudensky A,
Maliszewski CR, Maraskovski E: Developmental pathways of den-
dritic cells in vivo: distinct function, phenotype, and localiza-
tion of dendritic cell subsets in FLT3 ligand-treated mice. J
Immunol 1997, 159:2222-2231
30. Cella M, Jarrossay D, Facchetti F, Alebardi O, Nakajima H, Lanzavec-
chia A, Colonna M, et al: Plasmacytoid monocytes migrate to in-BMC Immunology 2002, 3 http://www.biomedcentral.com/1471-2172/3/15
Page 11 of 11
(page number not for citation purposes)
flamed lymph nodes and produce large amounts of type I
interferon. Nat Med 1999, 5:919-923
31. Nakano H, Yanagita M, Gunn MD: CD11c(+)B220(+)Gr-1(+) cells
in mouse lymph nodes and spleen display characteristics of
plasmacytoid dendritic cells. J Exp Med 2001, 194:1171-1178
32. Asselin-Paturel C, Boonstra A, Dalod M, Durand I, Yessaad N, Dezut-
ter-Dambuyant C, Vicari A, O'Garra A, Biron C, Briere F, Trinchieri
G: Mouse type I IFN-producing cells are immature APCs
with plasmacytoid morphology. Nat Immunol 2001, 2:1144-1150
33. Bjorck P: Isolation and characterization of plasmacytoid den-
dritic cells from Flt3 ligand and granulocyte-macrophage
colony-stimulating factor-treated mice. Blood 2001, 98:3520-
3526
34. Huang Q, Liu D, Majewski P, Schulte JC, Korn JM, Young RA, Lander
ES, Hacohen N: The plasticity of dendritic cell responses to
pathogens and their components. Science 2001, 294:870-875
35. McKenna HJ: Role of hematopoietic factors/flt3 ligand in ex-
pansion and regulation of dendritic cells. Curr Opin Hematol
2001, 8:149-154
36. Vremec D, Lieschke GJ, Dunn AR, Robb L, Metcalf D, Shortman K:
The influence of granulocyte/macrophage colony-stimulat-
ing factor on dendritic cell levels in mouse lymphoid organs.
Eur J Immunol 1997, 27:40-44
37. Randolph GJ, Inaba K, Robbiani DF, Steinman RM, Muller WA: Dif-
ferentiation of phagocytic monocytes into lymph node den-
dritic cells in vivo. Immunity 1999, 11:753-761
38. Mosmann T: Rapid colorimetric assay for cellular growth and
survival: application to proliferation and cytotoxicity. J Immu-
nol Methods 1983, 65:55-63
39. Fulcher DA, Lyons AB, Korn SL, Cook MC, Koleda C, Parish C, Faze-
kas de St Groth B, Basten A: The fate of self-reactive B-cells de-
pends primarily on the degree of antigen receptor
engagement and avaibility of T-cell help.  J Exp Med 1996,
183:2313-2328
40. Bourette RP, Arnaud S, Myles GM, Blanchet JP, Rohrschneider LR,
Mouchiroud G: Mona, a novel hematopoietic-specific adaptor
interacting with the macrophage colony-stimulating factor
receptor, is implicated in monocyte/macrophage develop-
ment. EMBO J 1998, 17:7273-7281
41. Arnett TR, Dempster DW: A comparative study of disaggregat-
ed chick and rat osteoclasts in vitro: effects of calcitonin and
prostaglandins. Endocrinology 1987, 120:602-608
42. Shadduck RK, Waheed A, Mangan KF, Rosenfeld CS: Preparation of
a monoclonal antibody directed against the receptor for
murine colony-stimulating factor-1. Exp Hematol 1993, 21:515-
520
Publish with BioMed Central    and   every 
scientist can read your work free of charge
"BioMedcentral will be the most significant development for 
disseminating the results of biomedical research in our lifetime."
Paul Nurse, Director-General, Imperial Cancer Research Fund
Publish with BMC and your research papers will be:
available free of charge to the entire biomedical community
peer reviewed and published immediately upon acceptance
cited in PubMed and archived on PubMed Central 
yours - you keep the copyright
editorial@biomedcentral.com
Submit your manuscript here:
http://www.biomedcentral.com/manuscript/
BioMedcentral.com